Data protection Impressum

Healthcare

In a significant step toward future pandemic preparedness, researchers at the University of Bern have uncovered a new mechanism by which coronaviruses manipulate human cells to replicate, offering a promising target for broad-spectrum antiviral therapies.

University of Bern researchers identify promising new strategy against coronaviruses

1 April 2025

Bern-based medtech company machineMD has announced a strategic partnership with Topcon Healthcare. The collaboration aims to integrate machineMD’s neurodiagnostic technology with Topcon’s digital health platform, paving the way for earlier and more precise detection of neurological diseases within a connected care ecosystem.

Neurodiagnostics specialist machineMD secures strategic investment from Topcon Healthcare

24 March 2025

A research team at .NeuroRestore (EPFL/CHUV/UNIL) has developed an innovative rehabilitation approach that combines robotic-assisted therapy with spinal cord stimulation, offering new hope for individuals with spinal cord injuries.

.NeuroRestore’s breakthrough in robotics and spinal stimulation restores mobility after paralysis

17 March 2025

Lausanne-based Limula has introduced LimONE, a fully automated cell therapy manufacturing platform designed to streamline production, reduce costs, and improve accessibility for patients. The company expects to deliver the first units by 2028.

Limula unveils LimONE, a breakthrough in automated cell therapy manufacturing

10 March 2025

Geneva-based Neurosoft Bioelectronics has set a new benchmark in neurotechnology with its high-resolution, stretchable brain interface for epilepsy monitoring. The EPFL spin-off successfully tested its device on two human patients, paving the way for broader clinical applications.

Neurosoft Bioelectronics advances brain interface technology for epilepsy and tinnitus

5 March 2025

Bernese start-up ATANIS Biotech has won Phase 2 of the FARE Innovation Award Diagnostic Challenge, securing USD 2 million to advance its FAST-PASE allergy test.

ATANIS Biotech secures USD 2 million for its FAST-PASE allergy test

3 March 2025

The University Hospitals of Geneva (HUG), the Department of Health and Mobilities (DSM) of the Canton of Geneva, and the Wyss Center are joining forces to establish Switzerland’s first artificial intelligence health hub at Campus Biotech, set to open in the second half of 2025.

An artificial intelligence health hub is set to open at Campus Biotech

17 February 2025

The University Hospitals of Geneva (HUG) have introduced Switzerland’s first AI-driven medical chatbot, “confIAnce”, providing reliable, verified general medical information. This innovation represents a major step in integrating artificial intelligence into Swiss healthcare.

HUG pioneers AI-powered healthcare with Switzerland’s first medical chatbot

10 February 2025

Biotech company CELLnTEC is playing a key role in the NEOLIVER project, a European-Swiss initiative developing the world’s first autologous bioprinted liver for clinical use. The project, co-funded by the EU and the Swiss government, aims to address the global organ donor shortage through innovative bioprinting technologies.

Bern-based CELLnTEC joins NEOLIVER project to develop bioprinted liver constructs

10 February 2025

The Foundation for Innovation and Technology has awarded Tech Grants to five promising projects from CHUV, EPFL, and HEIG-VD. The grants will support innovations in medical technology, robotics, and sustainable agriculture.

FIT awards Tech Grants to five cutting-edge projects from CHUV, EPFL and HEIG-VD

5 February 2025

1 … 6 7 8 9 10 11 12 13 14 … 24